Share this page!

Maybe Scrolly?
Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻 Profile picture
Twitter logo
4 Nov, 6 tweets, 3 min read
Radiance-HTN TRIO (investigative device)

Renal denervation

Elevated BP on 3 anti-hypertensives

Randomized (blinded)

Renal denervation vs sham

Follow-up for 6 months

Outcome BP and medication burden

#TCT2021
Tough design
Med adherence
Results
Difficult data for the denervation
Conclusion

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻

Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @DrDamluji

Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻 Profile picture
5 Nov
SURTAVI

No differences in death ,stroke, MI, or HF between TAVR and Surgery during longer follow-up

#TCT2021
Hemodynamics

Total AR and PVL

KCCQ no difference after 1 year

NYHA class at one year 1
Summary for SURTAVI

Self expanding valve

#TCT2021
Read 26 tweets
Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻 Profile picture
5 Nov
Cardiac Arrest and Cardiogenic Shock

There is a societal paper on this in the works too!

Very important work!

@Babar_Basir @venumenon10

#TCT2021 @TCTMD
Methylprednisone - ? not helpful

Advanced reperfusion strategies - small trial

#TCT2021
SCAI Shock Classification

Milrinone vs Dobutamine - no difference

Gaps in pressers in CICU setting: pressers and antiplatelets

@seanvandiepen @JasonKatzMD

#TCT2021
Read 20 tweets
Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻 Profile picture
5 Nov
The use of LV venting to prevent LV thrombus!

#TCT2021
Cardiogenic shock data: excellent presentation by @thiele_holger @HenrytTimothy

#TCT2021
Outcomes in registries = @InovaHealth is up there :)

NCSI data.

@Babar_Basir @BillONeillMD
Read 6 tweets
Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻 Profile picture
4 Nov
iFR vs FFR guided coronary Revascularization

iFR-Swedeheart 5 year outcomes

iFR vs FFR (randomized registry)

Study population: stable, unstable angina and NSTEMI

No loss to follow-up

#TCT2021
Results
No difference between iFR and FFR
Read 4 tweets
Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻 Profile picture
4 Nov
EROSION III

OCT vs angiography

Study population: STEMI

Randomized 1:1

Outcomes MACCE at 1 month and 1 year

#TCT2021
Results
Secondary endpoint and procedural data
Read 5 tweets
Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻 Profile picture
4 Nov
SUGAR trial @TCTMD

Cre8 EVO stent (70-80 microm) vs Zotarolimus DES stent

Study population: Patients with diabetics

Outcome target lesion failure (TLF) at 1 year

Design - non-inferiority trial
Procedural characteristics

between Cre8 EVO vs Resolute
anti platelets
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

Like this author's thread?

Get emails when @DrDamluji has new unrolls!

Check out other threads from @DrDamluji!

Read all threads by @DrDamluji

:(